← Back to Screener
Stryker Corporation (SYK)
Price$338.34
Favorite Metrics
Price vs S&P 500 (26W)-14.58%
Price vs S&P 500 (4W)-7.21%
Market Capitalization$129.77B
P/E Ratio (Annual)39.98x
Indicated Dividend Yield (Annual)1.03%
All Metrics
P/CF (Annual)25.73x
Book Value / Share (Quarterly)$58.61
P/TBV (Annual)8.03x
Indicated Dividend (Annual)$3.36
Revenue Growth (3Y)10.83%
Cash Flow / Share (Quarterly)$11.20
Payout Ratio (TTM)39.56%
Price vs S&P 500 (YTD)-6.46%
Gross Margin (TTM)64.57%
Net Profit Margin (TTM)12.92%
EPS (TTM)$8.40
10-Day Avg Trading Volume1.89M
EPS Excl Extra (TTM)$8.40
Revenue Growth (5Y)11.84%
EPS (Annual)$8.40
Dividend / Share (Annual)$3.36
ROI (Annual)8.48%
Gross Margin (Annual)64.57%
Net Profit Margin (5Y Avg)13.21%
Cash / Share (Quarterly)$10.72
P/E Basic Excl Extra (TTM)39.98x
Revenue Growth QoQ (YoY)11.42%
EPS Growth (5Y)14.84%
P/E Normalized (Annual)39.98x
ROA (Last FY)6.78%
Revenue Growth TTM (YoY)11.16%
EBITD / Share (TTM)$14.90
ROE (5Y Avg)14.72%
Operating Margin (TTM)19.43%
Cash Flow / Share (Annual)$11.20
P/B Ratio5.79x
P/B Ratio (Quarterly)6.00x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)5.64x
Net Interest Coverage (TTM)10.29x
ROA (TTM)6.93%
EPS Growth QoQ (YoY)55.37%
EV / EBITDA (TTM)24.59x
EPS Incl Extra (Annual)$8.40
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.04x
3-Month Avg Trading Volume1.99M
52-Week Price Return-0.97%
EV / Free Cash Flow (Annual)33.07x
P/E Incl Extra (TTM)39.98x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$43.76
P/S Ratio (Annual)5.17x
Asset Turnover (Annual)0.53x
52-Week High$404.87
Operating Margin (5Y Avg)17.04%
EPS Excl Extra (Annual)$8.40
CapEx CAGR (5Y)9.34%
Tangible BV CAGR (5Y)17.32%
26-Week Price Return-5.84%
Quick Ratio (Annual)1.04x
13-Week Price Return-4.47%
Total Debt / Equity (Annual)0.71x
Current Ratio (Quarterly)1.89x
Enterprise Value$141,618.39
Revenue / Share Growth (5Y)11.48%
Asset Turnover (TTM)0.54x
Book Value / Share Growth (5Y)11.00%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.76x
Pretax Margin (Annual)17.97%
Cash / Share (Annual)$10.72
3-Month Return Std Dev22.69%
Gross Margin (5Y Avg)64.02%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)16.78%
EBITDA Interim CAGR (5Y)25.83%
ROE (Last FY)14.48%
Net Interest Coverage (Annual)3.96x
EPS Basic Excl Extra (Annual)$8.40
P/FCF (TTM)30.30x
Receivables Turnover (TTM)6.26x
EV / Free Cash Flow (TTM)33.07x
Total Debt / Equity (Quarterly)0.71x
EPS Incl Extra (TTM)$8.40
Receivables Turnover (Annual)6.26x
ROI (TTM)8.63%
Dividend Growth Rate (5Y)7.89%
P/S Ratio (TTM)5.17x
Pretax Margin (5Y Avg)15.84%
Revenue / Share (Annual)$64.98
Tangible BV / Share (Annual)$43.76
Forward P/E22.56x
Free OCF CAGR (5Y)8.95%
Price vs S&P 500 (52W)-36.06%
P/E Ratio (TTM)39.98x
EPS Growth TTM (YoY)8.18%
Year-to-Date Return-2.32%
5-Day Price Return-1.13%
EPS Normalized (Annual)$8.40
ROA (5Y Avg)6.77%
Net Profit Margin (Annual)12.92%
Month-to-Date Return4.48%
Cash Flow / Share (TTM)$9.43
EBITD / Share (Annual)$14.83
EPS Growth (3Y)10.83%
Operating Margin (Annual)19.36%
LT Debt / Equity (Annual)0.66x
P/CF (TTM)25.73x
ROI (5Y Avg)8.50%
P/E Excl Extra (TTM)39.98x
LT Debt / Equity (Quarterly)0.66x
EPS Basic Excl Extra (TTM)$8.40
P/TBV (Quarterly)8.03x
Payout Ratio (Annual)39.56%
P/B Ratio (Annual)6.00x
Dividend / Share (TTM)$3.36
Inventory Turnover (TTM)1.76x
Pretax Margin (TTM)17.97%
Book Value / Share (Annual)$58.61
Price vs S&P 500 (13W)-7.34%
Net Margin Growth (5Y)3.01%
Dividend Yield (TTM)0.99%
Beta0.89x
P/FCF (Annual)30.30x
Revenue / Share (TTM)$64.98
ROE (TTM)15.04%
52-Week Low$319.32
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.06
4.06
4.08
4.08
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
GMEDGLOBUS MEDICAL INC | 4.37x | 30.08% | 67.41% | 20.33% | $96.82 |
About
Stryker manufactures and markets orthopedic implants, medical devices, and hospital equipment serving surgical and patient care settings. The company holds leading market positions in reconstructive orthopedics and operating room equipment, with products including joint replacements, endoscopy systems, robotics, and hospital beds. As one of the top three reconstructive orthopedic competitors, Stryker generates approximately one-quarter of revenues internationally.